Welcome to Dr. Elliott Antman's AHA Emerging Science™ Series.

AHA is proud to introduce a new program to further science collaboration hosted by Dr. Elliot Antman: The AHA Emerging Science™ Series webinars are one hour professional quality webinars held three times per year. Dr. Antman will host each webinar, which will have two 30 minute blocks, consisting of presentations of original research from the following categories:

  • Late Breaking Clinical Trials
  • Clinical Trial Updates of previously presented LBCTs
  • Late Breaking Basic Science
  • Major Bench-to-Bedside Advances
  • Major Conference Proceedings
  • Major Guidelines/Policy Statements

The live webinar events will be viewable from a computer or mobile phone, both live and on-demand. Attendees can ask questions electronically during the live event or post event. 

Join us at the next event, or view for past events by visiting the Emerging Science Series page on Professional Heart Daily.

Submit To AHA's Emerging Science™ Series!


Protecting Cerebrovascular Function- From Translational 
Science to Clinical Trials

Moderators: Robert O Bonow, Elliott Antman and Robert Harrington


Panelists: Jeffrey Weitz, John M Murkin and Mark Clay



Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial  

Jonathan P Piccini, Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC  


Discussion Q&A  



Cerebrovascular Autoregulation Impairment is Associated with Elevations in Plasma Glial Fibrillary Acidic Protein During Congenital Heart Surgery

Ronald B Easley, Baylor Coll of Med, Houston, TX


Discussion Q&A 


Questions or Comments?

Abstract Submission
Email: support@abstractsonline.com   
Phone: 217-398-1792
General Information
Email: sessions@heart.org   
Online: scientificsessions.org
Posted by Alyson PON Editor on Apr 27, 2012 9:54 AM America/Chicago

Leave a Comment

Log in to post a comment.

Login or Join

Login or Join to post a comment.